Michael Andriole

Michael Andriole

Directeur Général chez
Artios Pharma Ltd.
53 ans
Health Technology
Consumer Services

Profil

Michael T.
Andriole
currently works at Artios Pharma Ltd., as Chief Executive Officer & Director from 2025.
Mr. Andriole also formerly worked at Chimerix, Inc., as President, Chief Executive Officer & Director from 2023 to 2025, Eli Lilly & Co., as Vice President-Corporate Business Development from 2014 to 2017, and Endocyte, Inc., as Chief Financial Officer from 2017 to 2018.
Mr. Andriole received his Masters Business Admin degree from Kelley School of Business and undergraduate degree from Williams College of Business.

Postes actifs de Michael Andriole

SociétésPosteDébut
Directeur Général 12/08/2025

Anciens postes connus de Michael Andriole

SociétésPosteFin
CHIMERIX, INC. Directeur Général 21/04/2025
ENDOCYTE, INC. Directeur Financier/CFO 01/12/2018
ELI LILLY AND COMPANY Corporate Officer/Principal 01/02/2017
Voir l'expérience en détail de Michael Andriole

Formation de Michael Andriole

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Michael Andriole
🔇